Bioactive compounds might be helpful analysis instruments and drug leads, however it’s usually tough to establish their mechanism of motion or mobile goal. Right here we examine the potential for integration of chemical-genetic and genetic interplay information to disclose details about the pathways and targets of inhibitory compounds.
Making the most of the present full set of yeast haploid deletion mutants, we generated drug-hypersensitivity (chemical-genetic) profiles for 12 compounds. Along with a set of compound-specific interactions, the chemical-genetic profiles recognized a big group of genes required for multidrug resistance. Specifically, yeast mutants missing a practical vacuolar H(+)-ATPase present multidrug sensitivity, a phenomenon that could be conserved in mammalian cells.
By filtering chemical-genetic profiles for the multidrug-resistant genes after which clustering the compound-specific profiles with a compendium of large-scale genetic interplay profiles, we have been in a position to establish goal pathways or proteins. This technique thus gives a strong means for inferring mechanism of motion.
Sign transduction by focal adhesion kinase in most cancers.
Mobile interactions with furthermobile matrix play important roles in tumor initiation, development and metastasis. Focal adhesion kinase (FAK) is a cytoplasmic tyrosine kinase recognized as a key mediator of signaling by integrins, a significant household of cell floor receptors for furthermobile matrix, in addition to different receptors in each regular and most cancers cells.
FAK is activated by integrins by way of disruption of an auto-inhibitory intra-molecular interplay between its kinase area and the amino terminal FERM area. The activated FAK kinds a binary complicated with Src household kinases which might phosphorylate different substrates and set off a number of intramobile signaling pathways to control varied mobile features. Submobile localization of FAK in focal adhesions is important for FAK signaling, which is one other distinguishing function of the kinase.
Integrin-FAK signaling has been proven to activate a lot of signaling pathways by way of phosphorylation and protein-protein interactions to advertise tumorigenesis. FAK additionally performs a outstanding position in tumor development and metastasis by way of its regulation of each most cancers cells and their microenvironments together with most cancers cell migration, invasion, epithelial to mesenchymal transition, and angiogenesis.
Extra just lately, a task for FAK in tumor initiation and development has been demonstrated instantly utilizing xenograft in addition to conditional knockout mouse fashions. In settlement with these experimental information, overexpression and activation of FAK have been present in a wide range of human cancers.
Quite a lot of small molecule inhibitors for FAK have been developed and in varied phases of testing for most cancers therapies. General, the intensive analysis on FAK signaling in most cancers have yielded a wealth of knowledge on this pivotal kinase and these and future research are resulting in probably novel therapies for most cancers.
Neuroplasticity subserving motor ability studying.
Latest years have seen vital progress in our understanding of the neural substrates of motor ability studying. Advances in neuroimaging present new perception into practical reorganization related to the acquisition, consolidation, and retention of motor abilities.
Plastic adjustments involving structural reorganization in grey and white matter structure that happen over shorter time durations than beforehand thought have been documented as properly. Knowledge from experimental animals supplied essential info on believable mobile and molecular substrates contributing to mind reorganization underlying ability acquisition in people. Right here, we overview findings demonstrating practical and structural plasticity throughout totally different spatial and temporal scales that mediate motor ability studying whereas figuring out converging areas of curiosity and attainable avenues for future analysis.
Endotyping bronchial asthma: new insights into key pathogenic mechanisms in a fancy, heterogeneous illness.
Scientific bronchial asthma could be very extensively assumed to be the web results of extreme irritation pushed by aberrant T-helper-2 (Th2) immunity that results in infected, remodelled airways after which practical derangement that, in flip, causes signs.
This notion of illness is definitely poorly supported by information, and there are substantial discrepancies and really poor correlation between irritation, harm, practical impairment, and diploma of signs. Moreover, this drawback is compounded by the poor understanding of the heterogeneity of scientific illness. Failure to recognise and uncover the underlying mechanisms of those main variants or endotypes of bronchial asthma is, arguably, the key mental limitation to progress at current.
Luckily, each scientific analysis and animal fashions are very properly suited to dissecting the mobile and molecular foundation of illness endotypes. This method is already suggesting solely novel pathways to disease-eg, various macrophage specification, steroid refractory innate immunity, the interleukin-17-regulatory T-cell axis, epidermal progress issue receptor co-amplification, and Th2-mimicking however non-T-cell, interleukins 18 and 33 dependent processes that may supply sudden therapeutic alternatives for particular affected person endotypes.
Immunological elements of demyelinating illnesses.
Major demyelination within the central nervous system outcomes from harm to the myelin sheath or oligodendroglia and might be produced by a wide range of mechanisms, together with metabolic disturbances, toxicities, an infection, and autoimmunity. The main human demyelinating illness affecting the central nervous system is a number of sclerosis (MS).
Though the etiology of MS shouldn’t be recognized, present information point out that each genetic and environmental elements contribute to pathogenesis. Experimental allergic encephalomyelitis (EAE) is induced by immunization of genetically vulnerable animals with myelin proteins.
That is mediated by autoimmune T cells. Characterization of MHC restriction, high-quality specificity of antigen recognition, and T cell receptor (TCR) utilization by encephalitogenic T cells has resulted in extremely particular immunotherapies. Each HLA and TCR genes have been linked to susceptibility for MS which is extensively believed to be mediated by T cells that acknowledge an as but unidentified autoantigen.
Due to the advances within the understanding and therapy of EAE, current analysis in MS has been targeted on the characterization of mobile immune responses in opposition to myelin elements. The outcomes of those research are reviewed and the potential implications of those findings for the pathogenesis and future remedy of MS are examined.
Comparative proteomic evaluation of 11 frequent cell traces reveals ubiquitous however various expression of most proteins.
Deep proteomic evaluation of mammalian cell traces would yield a listing of the constructing blocks of essentially the most generally used techniques in organic analysis. Mass spectrometry-based proteomics can establish and quantify proteins in a worldwide and unbiased method and may spotlight the mobile processes which can be altered between such techniques.
We analyzed 11 human cell traces utilizing an LTQ-Orbitrap household mass spectrometer with a “excessive area” Orbitrap mass analyzer with improved decision and sequencing velocity. We recognized a complete of 11,731 proteins, and on common 10,361 ± 120 proteins in every cell line. This very excessive proteome protection enabled evaluation of a broad vary of processes and features.
Regardless of the distinct origins of the cell traces, our quantitative outcomes confirmed surprisingly excessive similarity by way of expressed proteins. Nonetheless, this international similarity of the proteomes didn’t suggest equal expression ranges of particular person proteins throughout the 11 cell traces, as we discovered vital variations in expression ranges for an estimated two-third of them.
The variability in mobile expression ranges was comparable for high and low abundance proteins, and even lots of the most extremely expressed proteins with family roles confirmed vital variations between cells. Metabolic pathways, which have excessive redundancy, exhibited variable expression, whereas primary mobile features such because the basal transcription equipment assorted a lot much less.
 CD27 |
|||
| PR27310 | Neuromics | 5 ug | EUR 229.2 |
 ELISA kit) Rat CD27 antigen(CD27) ELISA kit |
|||
| E02C1473-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Rat CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rat CD27 antigen(CD27) ELISA kit |
|||
| E02C1473-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Rat CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rat CD27 antigen(CD27) ELISA kit |
|||
| E02C1473-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Rat CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
 ELISA kit) Dog CD27 antigen(CD27) ELISA kit |
|||
| E08C1473-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Canine CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Dog CD27 antigen(CD27) ELISA kit |
|||
| E08C1473-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Canine CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Dog CD27 antigen(CD27) ELISA kit |
|||
| E08C1473-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Canine CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
 ELISA kit) Pig CD27 antigen(CD27) ELISA kit |
|||
| E07C1473-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Porcine CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Pig CD27 antigen(CD27) ELISA kit |
|||
| E07C1473-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Porcine CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Pig CD27 antigen(CD27) ELISA kit |
|||
| E07C1473-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Porcine CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
 ELISA kit) Goat CD27 antigen(CD27) ELISA kit |
|||
| E06C1473-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Goat CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Goat CD27 antigen(CD27) ELISA kit |
|||
| E06C1473-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Goat CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Goat CD27 antigen(CD27) ELISA kit |
|||
| E06C1473-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Goat CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
 ELISA kit) Human CD27 antigen(CD27) ELISA kit |
|||
| CSB-EL004910HU-24T | Cusabio | 1 plate of 24 wells | EUR 198 |
|
Description: Quantitativesandwich ELISA kit for measuring Human CD27 antigen (CD27) in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
|||
Human CD27 antigen(CD27) ELISA kit |
|||
| 1-CSB-EL004910HU | Cusabio |
|
|
|
Description: Quantitativesandwich ELISA kit for measuring Human CD27 antigen(CD27) in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
 ELISA kit) Mouse CD27 antigen(CD27) ELISA kit |
|||
| CSB-EL004910MO-24T | Cusabio | 1 plate of 24 wells | EUR 198 |
|
Description: Quantitativesandwich ELISA kit for measuring Mouse CD27 antigen (CD27) in samples from serum, plasma, cell culture supernates, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
|||
Mouse CD27 antigen(CD27) ELISA kit |
|||
| 1-CSB-EL004910MO | Cusabio |
|
|
|
Description: Quantitativesandwich ELISA kit for measuring Mouse CD27 antigen(CD27) in samples from serum, plasma, cell culture supernates, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
 ELISA Kit) Human CD27 Antigen (CD27) ELISA Kit |
|||
| 20-abx156729 | Abbexa |
|
|
Human CD27 antigen(CD27) ELISA kit |
|||
| E01C1473-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Human CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Human CD27 antigen(CD27) ELISA kit |
|||
| E01C1473-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Human CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Human CD27 antigen(CD27) ELISA kit |
|||
| E01C1473-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Human CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse CD27 antigen(CD27) ELISA kit |
|||
| E03C1473-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Mouse CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse CD27 antigen(CD27) ELISA kit |
|||
| E03C1473-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Mouse CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse CD27 antigen(CD27) ELISA kit |
|||
| E03C1473-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Mouse CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
 Mouse CD27 antigen, Cd27 ELISA KIT |
|||
| ELI-33094m | Lifescience Market | 96 Tests | EUR 1038 |
 Human CD27 antigen, CD27 ELISA KIT |
|||
| ELI-10382h | Lifescience Market | 96 Tests | EUR 988.8 |
 ELISA kit) Rabbit CD27 antigen(CD27) ELISA kit |
|||
| E04C1473-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Rabbit CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rabbit CD27 antigen(CD27) ELISA kit |
|||
| E04C1473-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Rabbit CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rabbit CD27 antigen(CD27) ELISA kit |
|||
| E04C1473-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Rabbit CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
 ELISA kit) Monkey CD27 antigen(CD27) ELISA kit |
|||
| E09C1473-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Monkey CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Monkey CD27 antigen(CD27) ELISA kit |
|||
| E09C1473-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Monkey CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Monkey CD27 antigen(CD27) ELISA kit |
|||
| E09C1473-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Monkey CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
 CD27 siRNA |
|||
| 20-abx910982 | Abbexa |
|
|
CD27 siRNA |
|||
| 20-abx910983 | Abbexa |
|
|
 CD27 Peptide |
|||
| 43-608P | ProSci | 0.1 mg | EUR 405.6 |
 CD27 antibody |
|||
| 10R-6372 | Fitzgerald | 100 ug | EUR 230.4 |
|
Description: Armenian Hamster monoclonal CD27 antibody |
|||
CD27 antibody |
|||
| 10R-6373 | Fitzgerald | 100 ug | EUR 268.8 |
|
Description: Armenian Hamster monoclonal CD27 antibody |
|||
CD27 antibody |
|||
| 10R-6374 | Fitzgerald | 100 ug | EUR 264 |
|
Description: Mouse monoclonal CD27 antibody |
|||
CD27 antibody |
|||
| 10R-7982 | Fitzgerald | 100 ug | EUR 586.8 |
|
Description: Armenian Hamster monoclonal CD27 antibody |
|||
CD27 antibody |
|||
| 10R-7983 | Fitzgerald | 100 ug | EUR 586.8 |
|
Description: American Hamster monoclonal CD27 antibody |
|||
CD27 antibody |
|||
| 70R-9668 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Affinity purified rabbit polyclonal CD27 antibody |
|||
CD27 antibody |
|||
| 70R-16264 | Fitzgerald | 50 ul | EUR 522 |
|
Description: Rabbit polyclonal CD27 antibody |
|||
 CD27 Antibody |
|||
| 32512-100ul | SAB | 100ul | EUR 302.4 |
CD27 Antibody |
|||
| 49854-100ul | SAB | 100ul | EUR 399.6 |
CD27 Antibody |
|||
| 49854-50ul | SAB | 50ul | EUR 286.8 |
CD27 Antibody |
|||
| ABD2296 | Lifescience Market | 100 ug | EUR 525.6 |
CD27 Antibody |
|||
| ABD6709 | Lifescience Market | 100 ug | EUR 525.6 |
CD27 Antibody |
|||
| DF6709 | Affbiotech | 200ul | EUR 420 |
CD27 Antibody |
|||
| DF2296 | Affbiotech | 200ul | EUR 420 |
CD27 Antibody |
|||
| 1-CSB-PA123791 | Cusabio |
|
|
|
Description: A polyclonal antibody against CD27. Recognizes CD27 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:50-1:200 |
|||
CD27 Antibody |
|||
| 1-CSB-PA149291 | Cusabio |
|
|
|
Description: A polyclonal antibody against CD27. Recognizes CD27 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:1000-1:5000, IHC:1:50-1:200 |
|||
CD27 Antibody |
|||
| 1-CSB-PA004910GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against CD27. Recognizes CD27 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
|||
CD27 Antibody |
|||
| 1-CSB-PA08235A0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against CD27. Recognizes CD27 from Human, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF; Recommended dilution: WB:1:500-1:5000, IHC:1:500-1:1000, IF:1:50-1:500 |
|||
CD27 Antibody |
|||
| F43213-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 140.25 |
|
Description: The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is required for generation and long-term maintenance of T cell immunity. It binds to ligand CD70, and plays a key role in regulating B-cell activation and immunoglobulin synthesis. This receptor transduces signals that lead to the activation of NF-kappaB and MAPK8/JNK. Adaptor proteins TRAF2 and TRAF5 have been shown to mediate the signaling process of this receptor. CD27-binding protein (SIVA), a proapoptotic protein, can bind to this receptor and is thought to play an important role in the apoptosis induced by this receptor. |
|||
CD27 Antibody |
|||
| F43213-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 322.15 |
|
Description: The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is required for generation and long-term maintenance of T cell immunity. It binds to ligand CD70, and plays a key role in regulating B-cell activation and immunoglobulin synthesis. This receptor transduces signals that lead to the activation of NF-kappaB and MAPK8/JNK. Adaptor proteins TRAF2 and TRAF5 have been shown to mediate the signaling process of this receptor. CD27-binding protein (SIVA), a proapoptotic protein, can bind to this receptor and is thought to play an important role in the apoptosis induced by this receptor. |
|||
CD27 Antibody |
|||
| R35484-100UG | NSJ Bioreagents | 100 ug | EUR 339.15 |
|
Description: Additional name(s) for this target protein: T-cell activation antigen CD27, T cell activation antigen S152 |
|||
CD27 Antibody |
|||
| R32373 | NSJ Bioreagents | 100 ug | EUR 356.15 |
|
Description: CD27 is a member of the tumor necrosis factor receptor superfamily. This receptor is required for generation and long-term maintenance of T cell immunity. It binds to ligand CD70, and plays a key role in regulating B-cell activation and immunoglobulin synthesis. And this receptor transduces signals that lead to the activation of NF-kappaB and MAPK8/JNK. Adaptor proteins TRAF2 and TRAF5 have been shown to mediate the signaling process of this receptor. CD27-binding protein (SIVA), a proapoptotic protein, can bind to this receptor and is thought to play an important role in the apoptosis induced by this receptor. |
|||
 Cd27 Antibody |
|||
| RQ6837 | NSJ Bioreagents | 100ug | EUR 356.15 |
|
Description: CD27 is a member of the tumor necrosis factor receptor superfamily. This receptor is required for generation and long-term maintenance of T cell immunity. It binds to ligand CD70, and plays a key role in regulating B-cell activation and immunoglobulin synthesis. And this receptor transduces signals that lead to the activation of NF-kappaB and MAPK8/JNK. Adaptor proteins TRAF2 and TRAF5 have been shown to mediate the signaling process of this receptor. CD27-binding protein (SIVA), a proapoptotic protein, can bind to this receptor and is thought to play an important role in the apoptosis induced by this receptor. |
|||
CD27 Antibody |
|||
| V3558-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: Recognizes a protein of a disulfide-linked 120kDa dimer, identified as CD27. It is expressed on the majority of peripheral T cells, medullary thymocytes, memory-type B cells, and natural killer cells. It is a transmembrane phosphoglycoprotein that belongs to the tumor necrosis factor receptor (TNFR) superfamily. CD27 binds to its ligand CD70, a member of the TNF family, and induces T-cell co-stimulation and B-cell activation. It also interacts with TRAFs and is involved in activation of NFkB and SAPK/JNK and induces apoptosis. |
|||
CD27 Antibody |
|||
| V3558-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
|
Description: Recognizes a protein of a disulfide-linked 120kDa dimer, identified as CD27. It is expressed on the majority of peripheral T cells, medullary thymocytes, memory-type B cells, and natural killer cells. It is a transmembrane phosphoglycoprotein that belongs to the tumor necrosis factor receptor (TNFR) superfamily. CD27 binds to its ligand CD70, a member of the TNF family, and induces T-cell co-stimulation and B-cell activation. It also interacts with TRAFs and is involved in activation of NFkB and SAPK/JNK and induces apoptosis. |
|||
CD27 Antibody |
|||
| V3558IHC-7ML | NSJ Bioreagents | 7 ml | EUR 349.3 |
|
Description: Recognizes a protein of a disulfide-linked 120kDa dimer, identified as CD27. It is expressed on the majority of peripheral T cells, medullary thymocytes, memory-type B cells, and natural killer cells. It is a transmembrane phosphoglycoprotein that belongs to the tumor necrosis factor receptor (TNFR) superfamily. CD27 binds to its ligand CD70, a member of the TNF family, and induces T-cell co-stimulation and B-cell activation. It also interacts with TRAFs and is involved in activation of NFkB and SAPK/JNK and induces apoptosis. |
|||
CD27 Antibody |
|||
| V3558SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: Recognizes a protein of a disulfide-linked 120kDa dimer, identified as CD27. It is expressed on the majority of peripheral T cells, medullary thymocytes, memory-type B cells, and natural killer cells. It is a transmembrane phosphoglycoprotein that belongs to the tumor necrosis factor receptor (TNFR) superfamily. CD27 binds to its ligand CD70, a member of the TNF family, and induces T-cell co-stimulation and B-cell activation. It also interacts with TRAFs and is involved in activation of NFkB and SAPK/JNK and induces apoptosis. |
|||
CD27 Antibody |
|||
| V3676-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is required for generation and long-term maintenance of T cell immunity. It binds to ligand CD70, and plays a key role in regulating B-cell activation and immunoglobulin synthesis. CD27 transduces signals that lead to the activation of NF-kB and MAPK8/JNK. Adaptor proteins TRAF2 and TRAF5 have been shown to mediate the signaling process of this receptor. CD27-binding protein (SIVA), a proapoptotic protein, can bind to this receptor and is thought to play an important role in the apoptosis induced by this receptor. [Wiki] |
|||
CD27 Antibody |
|||
| V3676-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
|
Description: The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is required for generation and long-term maintenance of T cell immunity. It binds to ligand CD70, and plays a key role in regulating B-cell activation and immunoglobulin synthesis. CD27 transduces signals that lead to the activation of NF-kB and MAPK8/JNK. Adaptor proteins TRAF2 and TRAF5 have been shown to mediate the signaling process of this receptor. CD27-binding protein (SIVA), a proapoptotic protein, can bind to this receptor and is thought to play an important role in the apoptosis induced by this receptor. [Wiki] |
|||
CD27 Antibody |
|||
| V3676IHC-7ML | NSJ Bioreagents | 7 ml | EUR 349.3 |
|
Description: The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is required for generation and long-term maintenance of T cell immunity. It binds to ligand CD70, and plays a key role in regulating B-cell activation and immunoglobulin synthesis. CD27 transduces signals that lead to the activation of NF-kB and MAPK8/JNK. Adaptor proteins TRAF2 and TRAF5 have been shown to mediate the signaling process of this receptor. CD27-binding protein (SIVA), a proapoptotic protein, can bind to this receptor and is thought to play an important role in the apoptosis induced by this receptor. [Wiki] |
|||
CD27 Antibody |
|||
| V3676SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is required for generation and long-term maintenance of T cell immunity. It binds to ligand CD70, and plays a key role in regulating B-cell activation and immunoglobulin synthesis. CD27 transduces signals that lead to the activation of NF-kB and MAPK8/JNK. Adaptor proteins TRAF2 and TRAF5 have been shown to mediate the signaling process of this receptor. CD27-binding protein (SIVA), a proapoptotic protein, can bind to this receptor and is thought to play an important role in the apoptosis induced by this receptor. [Wiki] |
|||
CD27 Antibody |
|||
| V3680-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: Recognizes a protein of a disulfide-linked 120kDa dimer, identified as CD27. It is expressed on the majority of peripheral T cells, medullary thymocytes, memory-type B cells, and natural killer cells. It is a transmembrane phosphoglycoprotein that belongs to the tumor necrosis factor receptor (TNFR) superfamily. CD27 binds to its ligand CD70, a member of the TNF family, and induces T-cell co-stimulation and B-cell activation. It also interacts with TRAFs and is involved in activation of NFkB and SAPK/JNK and induces apoptosis. |
|||
CD27 Antibody |
|||
| V3680-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
|
Description: Recognizes a protein of a disulfide-linked 120kDa dimer, identified as CD27. It is expressed on the majority of peripheral T cells, medullary thymocytes, memory-type B cells, and natural killer cells. It is a transmembrane phosphoglycoprotein that belongs to the tumor necrosis factor receptor (TNFR) superfamily. CD27 binds to its ligand CD70, a member of the TNF family, and induces T-cell co-stimulation and B-cell activation. It also interacts with TRAFs and is involved in activation of NFkB and SAPK/JNK and induces apoptosis. |
|||
CD27 Antibody |
|||
| V3680IHC-7ML | NSJ Bioreagents | 7 ml | EUR 349.3 |
|
Description: Recognizes a protein of a disulfide-linked 120kDa dimer, identified as CD27. It is expressed on the majority of peripheral T cells, medullary thymocytes, memory-type B cells, and natural killer cells. It is a transmembrane phosphoglycoprotein that belongs to the tumor necrosis factor receptor (TNFR) superfamily. CD27 binds to its ligand CD70, a member of the TNF family, and induces T-cell co-stimulation and B-cell activation. It also interacts with TRAFs and is involved in activation of NFkB and SAPK/JNK and induces apoptosis. |
|||
CD27 Antibody |
|||
| V3680SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: Recognizes a protein of a disulfide-linked 120kDa dimer, identified as CD27. It is expressed on the majority of peripheral T cells, medullary thymocytes, memory-type B cells, and natural killer cells. It is a transmembrane phosphoglycoprotein that belongs to the tumor necrosis factor receptor (TNFR) superfamily. CD27 binds to its ligand CD70, a member of the TNF family, and induces T-cell co-stimulation and B-cell activation. It also interacts with TRAFs and is involved in activation of NFkB and SAPK/JNK and induces apoptosis. |
|||
CD27 Antibody |
|||
| V2986-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: Recognizes a protein of a disulfide-linked 120kDa dimer, identified as CD27 (Workshop VI; Code 6T-028). CD27 is expressed on the majority of peripheral T cells, medullary thymocytes, memory-type B cells, and natural killer cells. It is a transmembrane phosphoglycoprotein that belongs to the tumor necrosis factor receptor (TNFR) superfamily. CD27 binds to its ligand CD70, a member of the TNF family, and induces T-cell co-stimulation and B-cell activation. It also interacts with TRAFs and is involved in activation of NFB and SAPK/JNK and induces apoptosis. |
|||
CD27 Antibody |
|||
| V2986-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
|
Description: Recognizes a protein of a disulfide-linked 120kDa dimer, identified as CD27 (Workshop VI; Code 6T-028). CD27 is expressed on the majority of peripheral T cells, medullary thymocytes, memory-type B cells, and natural killer cells. It is a transmembrane phosphoglycoprotein that belongs to the tumor necrosis factor receptor (TNFR) superfamily. CD27 binds to its ligand CD70, a member of the TNF family, and induces T-cell co-stimulation and B-cell activation. It also interacts with TRAFs and is involved in activation of NFB and SAPK/JNK and induces apoptosis. |
|||
CD27 Antibody |
|||
| V2986SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: Recognizes a protein of a disulfide-linked 120kDa dimer, identified as CD27 (Workshop VI; Code 6T-028). CD27 is expressed on the majority of peripheral T cells, medullary thymocytes, memory-type B cells, and natural killer cells. It is a transmembrane phosphoglycoprotein that belongs to the tumor necrosis factor receptor (TNFR) superfamily. CD27 binds to its ligand CD70, a member of the TNF family, and induces T-cell co-stimulation and B-cell activation. It also interacts with TRAFs and is involved in activation of NFB and SAPK/JNK and induces apoptosis. |
|||
CD27 Antibody |
|||
| V8229-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: Recognizes a protein of a disulfide-linked 120kDa dimer, identified as CD27. It is expressed on the majority of peripheral T cells, medullary thymocytes, memory-type B cells, and natural killer cells. It is a transmembrane phosphoglycoprotein that belongs to the tumor necrosis factor receptor (TNFR) superfamily. CD27 binds to its ligand CD70, a member of the TNF family, and induces T-cell co-stimulation and B-cell activation. It also interacts with TRAFs and is involved in activation of NFB and SAPK/JNK and induces apoptosis. |
|||
CD27 Antibody |
|||
| V8229-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
|
Description: Recognizes a protein of a disulfide-linked 120kDa dimer, identified as CD27. It is expressed on the majority of peripheral T cells, medullary thymocytes, memory-type B cells, and natural killer cells. It is a transmembrane phosphoglycoprotein that belongs to the tumor necrosis factor receptor (TNFR) superfamily. CD27 binds to its ligand CD70, a member of the TNF family, and induces T-cell co-stimulation and B-cell activation. It also interacts with TRAFs and is involved in activation of NFB and SAPK/JNK and induces apoptosis. |
|||
CD27 Antibody |
|||
| V8229SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: Recognizes a protein of a disulfide-linked 120kDa dimer, identified as CD27. It is expressed on the majority of peripheral T cells, medullary thymocytes, memory-type B cells, and natural killer cells. It is a transmembrane phosphoglycoprotein that belongs to the tumor necrosis factor receptor (TNFR) superfamily. CD27 binds to its ligand CD70, a member of the TNF family, and induces T-cell co-stimulation and B-cell activation. It also interacts with TRAFs and is involved in activation of NFB and SAPK/JNK and induces apoptosis. |
|||
CD27 Antibody |
|||
| V8725-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: Recognizes a protein of a disulfide-linked 120kDa dimer, identified as CD27. It is expressed on the majority of peripheral T cells, medullary thymocytes, memory-type B cells, and natural killer cells. It is a transmembrane phosphoglycoprotein that belongs to the tumor necrosis factor receptor (TNFR) superfamily. CD27 binds to its ligand CD70, a member of the TNF family, and induces T-cell co-stimulation and B-cell activation. It also interacts with TRAFs and is involved in activation of NF B and SAPK/JNK and induces apoptosis. |
|||
CD27 Antibody |
|||
| V8725-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
|
Description: Recognizes a protein of a disulfide-linked 120kDa dimer, identified as CD27. It is expressed on the majority of peripheral T cells, medullary thymocytes, memory-type B cells, and natural killer cells. It is a transmembrane phosphoglycoprotein that belongs to the tumor necrosis factor receptor (TNFR) superfamily. CD27 binds to its ligand CD70, a member of the TNF family, and induces T-cell co-stimulation and B-cell activation. It also interacts with TRAFs and is involved in activation of NF B and SAPK/JNK and induces apoptosis. |
|||
CD27 Antibody |
|||
| V8725SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: Recognizes a protein of a disulfide-linked 120kDa dimer, identified as CD27. It is expressed on the majority of peripheral T cells, medullary thymocytes, memory-type B cells, and natural killer cells. It is a transmembrane phosphoglycoprotein that belongs to the tumor necrosis factor receptor (TNFR) superfamily. CD27 binds to its ligand CD70, a member of the TNF family, and induces T-cell co-stimulation and B-cell activation. It also interacts with TRAFs and is involved in activation of NF B and SAPK/JNK and induces apoptosis. |
|||
CD27 Antibody |
|||
| V8726-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: Recognizes a protein of a disulfide-linked 120kDa dimer, identified as CD27. It is expressed on the majority of peripheral T cells, medullary thymocytes, memory-type B cells, and natural killer cells. It is a transmembrane phosphoglycoprotein that belongs to the tumor necrosis factor receptor (TNFR) superfamily. CD27 binds to its ligand CD70, a member of the TNF family, and induces T-cell co-stimulation and B-cell activation. It also interacts with TRAFs and is involved in activation of NF B and SAPK/JNK and induces apoptosis. |
|||
CD27 Antibody |
|||
| V8726-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
|
Description: Recognizes a protein of a disulfide-linked 120kDa dimer, identified as CD27. It is expressed on the majority of peripheral T cells, medullary thymocytes, memory-type B cells, and natural killer cells. It is a transmembrane phosphoglycoprotein that belongs to the tumor necrosis factor receptor (TNFR) superfamily. CD27 binds to its ligand CD70, a member of the TNF family, and induces T-cell co-stimulation and B-cell activation. It also interacts with TRAFs and is involved in activation of NF B and SAPK/JNK and induces apoptosis. |
|||
CD27 Antibody |
|||
| V8726SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: Recognizes a protein of a disulfide-linked 120kDa dimer, identified as CD27. It is expressed on the majority of peripheral T cells, medullary thymocytes, memory-type B cells, and natural killer cells. It is a transmembrane phosphoglycoprotein that belongs to the tumor necrosis factor receptor (TNFR) superfamily. CD27 binds to its ligand CD70, a member of the TNF family, and induces T-cell co-stimulation and B-cell activation. It also interacts with TRAFs and is involved in activation of NF B and SAPK/JNK and induces apoptosis. |
|||
 ELISA kit) Guinea pig CD27 antigen(CD27) ELISA kit |
|||
| E05C1473-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Guinea pig CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Guinea pig CD27 antigen(CD27) ELISA kit |
|||
| E05C1473-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Guinea pig CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Guinea pig CD27 antigen(CD27) ELISA kit |
|||
| E05C1473-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Guinea pig CD27 antigen(CD27) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
 Protein) T-cell Activation Antigen CD27 (CD27) Protein |
|||
| 20-abx260944 | Abbexa |
|
|
 Antibody) T-cell Activation Antigen CD27 (CD27) Antibody |
|||
| abx231453-100ug | Abbexa | 100 ug | EUR 577.2 |
T-cell Activation Antigen CD27 (CD27) Antibody |
|||
| 20-abx225088 | Abbexa |
|
|
T-cell Activation Antigen CD27 (CD27) Antibody |
|||
| 20-abx211067 | Abbexa |
|
|
T-cell Activation Antigen CD27 (CD27) Antibody |
|||
| 20-abx211217 | Abbexa |
|
|
T-cell Activation Antigen CD27 (CD27) Antibody |
|||
| abx139209-01mg | Abbexa | 0.1 mg | EUR 427.2 |
T-cell Activation Antigen CD27 (CD27) Antibody |
|||
| abx146709-100ug | Abbexa | 100 ug | EUR 526.8 |
T-cell Activation Antigen CD27 (CD27) Antibody |
|||
| abx147085-100ug | Abbexa | 100 ug | EUR 526.8 |
T-cell Activation Antigen CD27 (CD27) Antibody |
|||
| 20-abx111471 | Abbexa |
|
|
T-cell Activation Antigen CD27 (CD27) Antibody |
|||
| abx027573-400ul | Abbexa | 400 ul | EUR 627.6 |
T-cell Activation Antigen CD27 (CD27) Antibody |
|||
| abx027573-80l | Abbexa | 80 µl | EUR 343.2 |
T-cell Activation Antigen CD27 (CD27) Antibody |
|||
| abx432467-200ul | Abbexa | 200 ul | EUR 460.8 |
T-cell Activation Antigen CD27 (CD27) Antibody |
|||
| abx415298-01mg | Abbexa | 0.1 mg | EUR 543.6 |
T-cell Activation Antigen CD27 (CD27) Antibody |
|||
| abx415489-01mg | Abbexa | 0.1 mg | EUR 526.8 |
T-cell Activation Antigen CD27 (CD27) Antibody |
|||
| abx415492-1mg | Abbexa | 1 mg | EUR 994.8 |
T-cell Activation Antigen CD27 (CD27) Antibody |
|||
| abx414870-025mg | Abbexa | 0.25 mg | EUR 678 |
T-cell Activation Antigen CD27 (CD27) Antibody |
|||
| 20-abx001588 | Abbexa |
|
|
T-cell Activation Antigen CD27 (CD27) Antibody |
|||
| 20-abx306428 | Abbexa |
|
|
) Recombinant Cynomolgus CD27 molecule/CD27(C-6His) |
|||
| C960-10ug | Novoprotein | 10ug | EUR 187.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mMTris,150mM NaCl,pH8.5. |
|||
Recombinant Cynomolgus CD27 molecule/CD27(C-6His) |
|||
| C960-1mg | Novoprotein | 1mg | EUR 2739.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mMTris,150mM NaCl,pH8.5. |
|||
Recombinant Cynomolgus CD27 molecule/CD27(C-6His) |
|||
| C960-500ug | Novoprotein | 500ug | EUR 1935.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mMTris,150mM NaCl,pH8.5. |
|||
Recombinant Cynomolgus CD27 molecule/CD27(C-6His) |
|||
| C960-50ug | Novoprotein | 50ug | EUR 442.8 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mMTris,150mM NaCl,pH8.5. |
|||
Recombinant Cynomolgus CD27 molecule/CD27(C-6His) |
|||
| CA62-10ug | Novoprotein | 10ug | EUR 242.4 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
|||
Recombinant Cynomolgus CD27 molecule/CD27(C-6His) |
|||
| CA62-1mg | Novoprotein | 1mg | EUR 2983.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
|||
Recombinant Cynomolgus CD27 molecule/CD27(C-6His) |
|||
| CA62-500ug | Novoprotein | 500ug | EUR 1935.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
|||
Recombinant Cynomolgus CD27 molecule/CD27(C-6His) |
|||
| CA62-50ug | Novoprotein | 50ug | EUR 595.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
|||
 Antibody (PE)) T-cell Activation Antigen CD27 (CD27) Antibody (PE) |
|||
| abx200209-100tests | Abbexa | 100 tests | EUR 594 |
T-cell Activation Antigen CD27 (CD27) Antibody (PE) |
|||
| abx139211-100tests | Abbexa | 100 tests | EUR 577.2 |
 Antibody (APC)) T-cell Activation Antigen CD27 (CD27) Antibody (APC) |
|||
| abx200210-100tests | Abbexa | 100 tests | EUR 861.6 |
T-cell Activation Antigen CD27 (CD27) Antibody (APC) |
|||
| abx139212-100tests | Abbexa | 100 tests | EUR 577.2 |
T-cell Activation Antigen CD27 (CD27) Antibody (APC) |
|||
| abx415296-100tests | Abbexa | 100 tests | EUR 861.6 |
 Antibody (RPE)) T-cell Activation Antigen CD27 (CD27) Antibody (RPE) |
|||
| abx415299-100tests | Abbexa | 100 tests | EUR 861.6 |
T-cell Activation Antigen CD27 (CD27) Antibody (RPE) |
|||
| abx415490-100tests | Abbexa | 100 tests | EUR 710.4 |
T-cell Activation Antigen CD27 (CD27) Antibody (RPE) |
|||
| abx415491-25tests025ml | Abbexa | 25 tests (0.25 ml) | EUR 376.8 |
T-cell Activation Antigen CD27 (CD27) Antibody (RPE) |
|||
| abx414873-01mg | Abbexa | 0.1 mg | EUR 710.4 |
 Antibody (HRP)) T-cell Activation Antigen CD27 (CD27) Antibody (HRP) |
|||
| 20-abx306429 | Abbexa |
|
|
 Antibody) CD27(203.6) Antibody |
|||
| BNCA0163-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against CD27(203.6), APC conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC800163-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD27(203.6), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC800163-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD27(203.6), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC810163-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD27(203.6), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC810163-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD27(203.6), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC940163-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD27(203.6), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC940163-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD27(203.6), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC700163-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD27(203.6), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC700163-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD27(203.6), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC880163-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD27(203.6), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC880163-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD27(203.6), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC430163-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD27(203.6), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC430163-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD27(203.6), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC400163-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD27(203.6), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC400163-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD27(203.6), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC050163-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD27(203.6), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC050163-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD27(203.6), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNCB0163-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD27(203.6), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNCB0163-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD27(203.6), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNCAP0163-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD27(203.6), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNCAP0163-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD27(203.6), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNCR0163-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against CD27(203.6), RPE conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNCP0163-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against CD27(203.6), PerCP conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNUM0163-50 | Biotium | 50uL | EUR 474 |
|
Description: Primary antibody against CD27(203.6), 1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNCH0163-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD27(203.6), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNCH0163-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD27(203.6), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNUB0163-100 | Biotium | 100uL | EUR 250.8 |
|
Description: Primary antibody against CD27(203.6), Concentration: 0.2mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNUB0163-500 | Biotium | 500uL | EUR 549.6 |
|
Description: Primary antibody against CD27(203.6), Concentration: 0.2mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC040163-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD27(203.6), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC040163-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD27(203.6), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC550163-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD27(203.6), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC550163-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD27(203.6), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC610163-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD27(203.6), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC610163-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD27(203.6), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC680163-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD27(203.6), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC680163-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD27(203.6), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC470163-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD27(203.6), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD27(203.6) Antibody |
|||
| BNC470163-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD27(203.6), CF647 conjugate, Concentration: 0.1mg/mL |
|||
 Antibody (FITC)) T-cell Activation Antigen CD27 (CD27) Antibody (FITC) |
|||
| abx200208-100tests | Abbexa | 100 tests | EUR 510 |
T-cell Activation Antigen CD27 (CD27) Antibody (FITC) |
|||
| abx139213-100tests | Abbexa | 100 tests | EUR 510 |
T-cell Activation Antigen CD27 (CD27) Antibody (FITC) |
|||
| abx415297-01mg | Abbexa | 0.1 mg | EUR 777.6 |
T-cell Activation Antigen CD27 (CD27) Antibody (FITC) |
|||
| abx415488-01mg | Abbexa | 0.1 mg | EUR 610.8 |
T-cell Activation Antigen CD27 (CD27) Antibody (FITC) |
|||
| abx414872-01mg | Abbexa | 0.1 mg | EUR 610.8 |
T-cell Activation Antigen CD27 (CD27) Antibody (FITC) |
|||
| 20-abx306430 | Abbexa |
|
|
 Antibody (Biotin)) T-cell Activation Antigen CD27 (CD27) Antibody (Biotin) |
|||
| abx414871-01mg | Abbexa | 0.1 mg | EUR 610.8 |
T-cell Activation Antigen CD27 (CD27) Antibody (Biotin) |
|||
| 20-abx306431 | Abbexa |
|
|
 CD27, Fc fusion |
|||
| 71176 | BPS Bioscience | 100 µg | EUR 320 |
|
Description: Human secreted CD27, Fc fusion protein, also known as Tumor Necrosis Factor Receptor Superfamily Member 7, TNFRSF7, and T14, GenBank Accession No. NM_001242, a.a. 21-192 expressed in a HEK293 cell expression system. MW = 45.8 kDa (monomer). This protein runs at a higher MW by SDS-PAGE due to glycosylation. |
|||
 CD27 Rabbit mAb |
|||
| A11505 | Abclonal | 20 μL | EUR 18 |
 CD27 Rabbit pAb |
|||
| A15654-100ul | Abclonal | 100 ul | EUR 369.6 |
CD27 Rabbit pAb |
|||
| A15654-200ul | Abclonal | 200 ul | EUR 550.8 |
CD27 Rabbit pAb |
|||
| A15654-20ul | Abclonal | 20 ul | EUR 219.6 |
CD27 Rabbit pAb |
|||
| A15654-50ul | Abclonal | 50 ul | EUR 267.6 |
CD27 Rabbit pAb |
|||
| A1945-100ul | Abclonal | 100 ul | EUR 369.6 |
CD27 Rabbit pAb |
|||
| A1945-200ul | Abclonal | 200 ul | EUR 550.8 |
CD27 Rabbit pAb |
|||
| A1945-20ul | Abclonal | 20 ul | EUR 219.6 |
CD27 Rabbit pAb |
|||
| A1945-50ul | Abclonal | 50 ul | EUR 267.6 |
) CD27 antibody (PE) |
|||
| 61R-1230 | Fitzgerald | 100 ug | EUR 379.2 |
|
Description: Armenian Hamster monoclonal CD27 antibody (PE) |
|||
) CD27 antibody (FITC) |
|||
| 61R-1068 | Fitzgerald | 100 ug | EUR 249.6 |
|
Description: Armenian Hamster monoclonal CD27 antibody (FITC) |
|||
 anti- CD27 antibody |
|||
| FNab01453 | FN Test | 100µg | EUR 606.3 |
|
Description: Antibody raised against CD27 |
|||
 Human CD27 Antibody |
|||
| 32149-05111 | AssayPro | 150 ug | EUR 313.2 |
 CD27 cloning plasmid |
|||
| CSB-CL004910HU-10ug | Cusabio | 10ug | EUR 279.6 |
|
Description: A cloning plasmid for the CD27 gene. |
|||
) CD27 antibody (biotin) |
|||
| 61R-1486 | Fitzgerald | 100 ug | EUR 262.8 |
|
Description: Armenian Hamster monoclonal CD27 antibody (biotin) |
|||
CD27 antibody (biotin) |
|||
| 61R-1487 | Fitzgerald | 100 ug | EUR 379.2 |
|
Description: Mouse monoclonal CD27 antibody (biotin) |
|||
 CD27 Blocking Peptide |
|||
| 33R-5024 | Fitzgerald | 100 ug | EUR 216 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CD27 antibody, catalog no. 70R-9668 |
|||
CD27 Blocking Peptide |
|||
| DF6709-BP | Affbiotech | 1mg | EUR 234 |
CD27 Blocking Peptide |
|||
| DF2296-BP | Affbiotech | 1mg | EUR 234 |
 CD27 Conjugated Antibody |
|||
| C49854 | SAB | 100ul | EUR 476.4 |
 CD27 Polyclonal Antibody |
|||
| A1074-100 | Biovision | each | EUR 261.6 |
 CD27 Recombinant Protein |
|||
| 91-931 | ProSci | 0.05 mg | EUR 405.6 |
|
Description: CD27 antigen is also known as CD27L receptor, T-cell activation antigen CD27, Tumor necrosis factor receptor superfamily member 7, T14 and TNFRSF7. In humans, it is encoded by the CD27 gene. CD27 is a single-pass type I membrane protein with 3 TNFR-Cys repeats. It is a member of the TNF-receptor superfamily and is required for generation and long-term maintenance of T cell immunity. It binds to ligand CD70, and plays a key role in regulating B-cell activation and immunoglobulin synthesis. It plays a role in survival of activated T-cells and apoptosis through association with SIVA1. |
|||
CD27 Recombinant Protein |
|||
| 90-390 | ProSci | 100 ug | EUR 651.3 |
|
Description: CD27 (TNFRSF7) is a member of the TNF-receptor superfamily limited to cells of the lymphoid lineage and exists as both a dimeric glycoprotein on the cell surface and as a soluble protein in serum. As a T and B cell co-stimulatory molecule, the activity of CD27 is governed by its TNF-like ligand CD70 on lymphocytes and dendritic cells. The CD27-CD70 interaction is required for Th1 generation responses to differentiation signals and long-term maintenance of T cell immunity, and meanwhile, plays a key role in regulating B cell differentiation, activation and immunoglobulin synthesis. The CD27 receptor transduces signals and subsequently leads to the activation of NF-kappaB and MAPK8/JNK, mediated by the adaptor proteins TRAF2 and TRAF5. In addition, the proapoptotic protein SIVA is capable of binding the cytoplasmic tail of CD27 and exerts action in the process of apoptosis. |
|||
CD27 Recombinant Protein |
|||
| 90-391 | ProSci | 50 ug | EUR 619.8 |
|
Description: CD27 (TNFRSF7) is a member of the TNF-receptor superfamily limited to cells of the lymphoid lineage and exists as both a dimeric glycoprotein on the cell surface and as a soluble protein in serum. As a T and B cell co-stimulatory molecule, the activity of CD27 is governed by its TNF-like ligand CD70 on lymphocytes and dendritic cells. The CD27-CD70 interaction is required for Th1 generation responses to differentiation signals and long-term maintenance of T cell immunity, and meanwhile, plays a key role in regulating B cell differentiation, activation and immunoglobulin synthesis. The CD27 receptor transduces signals and subsequently leads to the activation of NF-kappaB and MAPK8/JNK, mediated by the adaptor proteins TRAF2 and TRAF5. In addition, the proapoptotic protein SIVA is capable of binding the cytoplasmic tail of CD27 and exerts action in the process of apoptosis. |
|||
CD27 Polyclonal Antibody |
|||
| A70588 | EpiGentek |
|
|
CD27 Polyclonal Antibody |
|||
| ABP58051-003ml | Abbkine | 0.03ml | EUR 189.6 |
|
Description: A polyclonal antibody for detection of CD27 from Human. This CD27 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human CD27 protein at amino acid sequence of 1-80 |
|||
CD27 Polyclonal Antibody |
|||
| ABP58051-01ml | Abbkine | 0.1ml | EUR 346.8 |
|
Description: A polyclonal antibody for detection of CD27 from Human. This CD27 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human CD27 protein at amino acid sequence of 1-80 |
|||
CD27 Polyclonal Antibody |
|||
| ABP58051-02ml | Abbkine | 0.2ml | EUR 496.8 |
|
Description: A polyclonal antibody for detection of CD27 from Human. This CD27 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human CD27 protein at amino acid sequence of 1-80 |
|||
CD27 Polyclonal Antibody |
|||
| A50648 | EpiGentek |
|
|
CD27 Polyclonal Antibody |
|||
| ES10514-100ul | ELK Biotech | 100ul | EUR 334.8 |
|
Description: A Rabbit Polyclonal antibody against CD27 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
|||
CD27 Polyclonal Antibody |
|||
| ES10514-50ul | ELK Biotech | 50ul | EUR 248.4 |
|
Description: A Rabbit Polyclonal antibody against CD27 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
|||
 Antibody (PerCP-Cy5.5)) T-cell Activation Antigen CD27 (CD27) Antibody (PerCP-Cy5.5) |
|||
| abx200211-100tests | Abbexa | 100 tests | EUR 577.2 |
) CD27 antibody (allophycocyanin) |
|||
| 61R-1716 | Fitzgerald | 100 ug | EUR 573.6 |
|
Description: Armenian Hamster monoclonal CD27 antibody (allophycocyanin) |
|||
 Antibody (PE-DyLight 594)) T-cell Activation Antigen CD27 (CD27) Antibody (PE-DyLight 594) |
|||
| abx139210-100tests | Abbexa | 100 tests | EUR 627.6 |
 Anti-Hu CD27 PE |
|||
| 1P-308-T025 | ExBio | 25 tests | EUR 168 |
Anti-Hu CD27 PE |
|||
| 1P-308-T100 | ExBio | 100 tests | EUR 288 |
We harness data of those cell line proteomes for the development of a broad protection “super-SILAC” quantification commonplace. Along with the accompanying paper (Schaab, C. MCP 2012, PMID: 22301388) (17) these information can be utilized to acquire reference expression profiles for proteins of curiosity each inside and throughout cell line proteomes.